Lenvatinib - Globe Thesis

Keyword [Lenvatinib] Result: 21 - 40 \| Page: 2 of 3
21.	Clinical Efficacy And Related Biomarker Of TACE Combined With Targeted Immunotherapy For Unresectable Hepatocellular Carcinoma
22.	Comparative Analysis Of The Proliferation And Related Signaling Pathways Based On Proteomics Of Human Hepatoma Cells Treated By Three Multi-RTK Inhibitors
23.	Role Of NAT10-mediated RNA Acetylation Ac4C-modified HSP90AA1 In Endoplasmic Reticulum Stress-mediated Lenvatinib Resistance In Hepatocellular Carcinoma Cells
24.	The Role Of Endoplasmic Reticulum Stress-regulated ARHGEF2 In Angiogenesis And Sensitivity To Lenvatinib In Hepatocellular Carcinoma
25.	Dicer Enhances The Anti-Tumor Effect Of Lenvatinib Through Interleukin-8 In Hepatocellular Carcinoma And The Relationship Between Interleukin-8 And Immune Related Adverse Events
26.	BRAF Mutation Regulates ARNTL-mediated Lenvatinib Resistance In Thyroid Carcinoma
27.	Preparation Of Reduction-response Lenvatinib Nanomedicine And Its Application For Treatment Of Hepatocellular Carcinoma
28.	Clinical Practice Of Targeted And Immunotherapy For Hepatocellular Carcinoma And Research On Related Biomarker
29.	Efficacy And Adverse Effects Of Lenvatinib And Immune Checkpoint Inhibitors In Advanced Primary Hepatocellular Carcinoma
30.	Effect Of Preoperative Application Of Lenvatinib On Liver Regeneration After Hepatectomy In Mice And The Molecular Mechanism Of Liver Regeneration
31.	Lenvatinib Inhibited Huh-7 Cell Migration And Invasion Via The UHRF1/DNMT1 Axis
32.	Clinical Efficacy Of Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Monoclonal Antibody And Lenvatinib For Middle-advanced Stage Hepatocellular Carcinoma
33.	Efficacy And Safety Of Hepatic Arterial Infusion Chemotherapy Combined With Lenvatinib And PD-1 Inhibitors For Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
34.	Clinical Study Of Hepatic Arterial Infusion Chemotherapy Combined With Anti-PD-1 Antibody And Lenvatinib In The Treatment Of Unresectable Hepatocellular Carcinoma
35.	To Explore The Change Of Tumor-feeding Artery Diameter After Hepatic Artery Infusion Chemotherapy Plus Lenvatinib Treatment And The Relation With Clinical Efficacy
36.	A Network Meta-analysis Of The Effect Of Different Combination Regimens On Prognosis Of Liver Cancer Based On Lenvatinib
37.	Analysis Of The Mid-term Efficacy Of TACE Combined With Terelizumab And Lenvatinib In The Treatment Of ’ TACE Resistant ’ Liver Cancer
38.	Study Of The Mechanism Of Siglec-15 Regulation By Lenvatinib Based On FXR/RXRα Interactions
39.	Clinical Study Of Lenvatinib Combined With Sintilimab In Adjuvant Treatment Of Patients With High Risk Of Recurrence Of Postoperative Hepatocellular Carcinoma
40.	Quercetin Enhances The Anti-Hepatocellular Carcinoma Effect Of Lenvatinib By Inhibiting P-ERK5/β-catenin
<<First <Prev Next> Last>> Jump to